The US has developed two of the vaccines, Moderna and Johnson & Johnson (Janssen), and with German science, produced and marketed a third, Pfizer-BioNTech. China has developed and marketed three major vaccines – Sinopharm, CoronaVac, Convidecia – and several minor ones. India has produced more than three, as have Cuba and Iran. Turkey, Kazakhstan, and the UK have produced one each; the last of them, Oxford-Astra-Zeneca is the runner-up to Pfizer in reach
worldwide. France’s
Sanofi has produced one, but it has yet to reach market.
Russia has produced three Covid-19 vaccines – Sputnik (Sputnik V and Sputnik Lite), EpiVacCorona, and CoviVac.
Vaccine market entry decided by national and international regulators is a measure of political and corporate power; global dosage totals are the result. Pfizer has dominated the European Union market with roughly
three times the number of doses administered than all its competitors combined. In rank
order after Pfizer come Moderna, Astra-Zeneca, Johnson & Johnson, Sputnik, Sinovac and Sinopharm.
In the US market, Pfizer dominates with a 59% share; Moderna with 38%; Johnson & Johnson with just 3%. Non-American vaccines
have been kept out of the American market entirely. That isn’t the result of
science.
But in the world as a whole,
China and India lead in the aggregate of doses; Cuba, the United Arab Emirates, and Chile lead in the number of doses administered per hundred people.
By contrast with the global and European standards, Russians have been more resistant to vaccination
and more skeptical of the science. With a dosage per hundred people of 111, the Russian
vaccination rate has been half the European Union average; a third the US rate; about equal to Honduras or Pakistan.
In the Russian market this is the short story of CoviVac — the vaccine which has tried to make its way against oligarch money, Moscow politics, and
the paradoxical contest of one of the most advanced vaccine science establishments in the world with one of the most coronavirus skeptical of populations.
During 2021 the Russian government announced its target was to vaccinate about 60% of the population, or about 88 million people. According to this year’s data,
full vaccination has been achieved for 49%; one dose for 54%.
By
May of 2020, Russia’s state-financed medical research centres were reported to be experimenting with prototypes of four dozen vaccines. By mid-year, however, government officials in Moscow had decided with business leaders that just three vaccines and three companies would be selected for the full cycle of development, testing, mass production, and national distribution.
The first vaccine of the three was Gam-Covid-Vac, trademark Sputnik V; it was registered in August 2020, and was developed by the Gamalei National Research Center for Epidemiology and Microbiology. The second was EpiVacCorona, developed by Vector, the Federal State Scientific Center for Virology and Biotechnology, and launched in October 2020. The third, CoviVac, was invented by the Chumakov Federal Scientific Center for Research and Development of Immunobiological Drugs, and registered in February 2021. Sputnik is a viral vector type; EpiVacCorona a peptide vector type; CoviVac an inactivated type; for the biochemical differences between the types, read
this. The Russian vaccines
do not use mRNA technology.
At the same time as these vaccines were being rushed to market, public Russian resistance to vaccination was growing, while the readiness to be vaccinated was dropping. Age, education and urban residence – middle-class factors – appear to have increased skepticism towards the vaccines rather than encouraged compliance with the government’s vaccination
policy. Discrimination between the vaccine types also began to appear in public. “Usually, those who want CoviVac are older,”
reported this US academic assessment of November 2021. “Some believe that they might experience fewer negative side effects than with Sputnik V, and they also think [CoviVac] was created with better technology because they could spend more time [developing] it.”
Source for both tables:
https://www.levada.ru/ -- published in April 2021.
As the year 2021 wore on and infection rates rose, the resistance to vaccination softened. However,
opposition to mandatory vaccination and policing systems like the QR code hardened. The Levada polling group in Moscow
reported: “
More than half of respondents do not support it (35% are completely against it, 19% are rather unsupportive). 42% of Russians are in favour of the idea: 21% of Russians support universal mandatory vaccination of the population in some way.”
Source:
https://www.levada.ru/
News
️In a speech in the German Bundestag, 23-year-old MP Emilia Fester (she) of the party "Die Grünen" (The Greens) accuses the non-vaccinated and the conservative party "AfD", which criticises the measures, of still not having recovered her basic rights.
️- 
And all that I miss so much, it may sound ridiculous to you, but you know what is really ridiculous? If you and your freedom-loving friends had simply gotten vaccinated when most of us had the good sense to do that simple thing, then I'd be free again now.
- This author-victim inversion is the result of 2 years of Psyops.
